So before anyone can be dosed on the open label extension, the FDA must approve Cytodyn's submission tomorrow, and then the CD12 hosptial sites need an IRB approval subsequent to the FDA approval.

So seems for sure that no one will be dosed on open label extension until Tuesday at the earliest.